Marijuana stock investors are back waiting for another rise in trading. These last few weeks have been a window of upward trading and stronger momentum. Not only did this show the possibilities of stronger trading in the future, but it also restored investors' confidence. For a long while, the cannabis sector has been on a consistent downtrend due to the politics around reform. Now that Donald Trump has voiced his concerns about federal reform for cannabis, most marijuana stocks have seen better trading.
The U.S. cannabis industry is growing rapidly. Legal sales are expected to reach $45 billion in 2025 alone. Additionally, the sector is projected to grow at a double-digit rate annually over the decade. Adult-use marijuana is now legal in nearly half of all U.S. states. Furthermore, tax revenues continue rising as more states launch legal markets. Job creation within the industry has surpassed many other sectors. As a result, investor attention has shifted toward undervalued marijuana penny stocks. These low-priced equities often carry more volatility. Therefore, using technical analysis is essential when trading them. Identifying key support and resistance zones can enhance entry and exit points. However, success also requires managing downside risk. Setting stop losses and controlling position size can help limit exposure. This week, traders are watching several names for breakouts. Industry growth, combined with policy momentum, may create short-term price action worth trading.
Some of the top marijuana stocks are still struggling to gain momentum in the market. Although this may be true for some companies, others are doing well and showing why legal cannabis makes a difference. To date, almost all of the USA and many global regions have legalized cannabis. In the US, companies were able to report strong 2025 quarterly earnings. These results range from increases in revenue and business development.
FLUENT CORP (OTCQB:CNTMF) Q4 2024 Earnings Conference Call April 17, 2025 4:30 PM ET Company Participants Robert Beasley - Chief Executive Officer Patricia Fonseca - Chief Financial Officer Conference Call Participants Brian Manning - New Normal Investments Operator Good afternoon, ladies and gentlemen. Welcome to FLUENT's Fourth Quarter and Full-Year 2024 Conference Call.
The legal operators are now facing the reality of how Donald Trump's tariffs will impact the cannabis industry. For the ancillary side of the cannabis industry, many products are made overseas. Places like China are deep into the cannabis industry. Some of the companies are known for manufacturing vaporizer parts and packaging solutions. Now with tariffs in place things that were once more affordable for cannabis consumers will ultimately go up in price.
The U.S. cannabis industry continues to experience significant growth, thereby presenting investors with numerous opportunities. Notably, the legal cannabis market added approximately $115.2 billion to the U.S. economy in 2024. Furthermore, projections indicate that legal recreational cannabis sales in the United States are expected to reach nearly $58 billion by 2030. As a result, this robust expansion highlights the sector's potential, ultimately making it an attractive consideration for investors.
Is there a need to fear marijuana stock investing even after all the growth and progress? Some may still have their doubts but you can not deny how far along things have come in the last 5 years. Over half of the United States legalized cannabis. Canada became the first G7 nation to pass reform as well. More and more places around the globe are joining the green rush expanding the cannabis industry and opportunity even further.
In 2024, the US cannabis industry has continued to experience rapid growth, with marijuana stocks posting significant year-to-date gains. The US cannabis market was valued at $13.2 billion in 2023 and is expected to reach $42 billion by 2025. Recent news about federal legalization efforts, particularly the SAFE Banking Act, has fueled investor optimism. This act would allow cannabis businesses to access traditional banking services, a significant hurdle in the industry. As states continue to legalize recreational and medical marijuana, the market is poised for further expansion.
The US cannabis industry continues to experience rapid growth, making marijuana stocks a popular choice for investors. 2023 the US cannabis market was valued at approximately $33 billion. Experts predict it will grow to over $50 billion by 2028. This growth is driven by the increasing legalization of recreational and medical cannabis across states. Recent news about federal cannabis reform, including potential banking access for cannabis businesses, has further boosted investor confidence. As more states and the federal government explore legalization, many anticipate significant changes that could expand the industry.
So far this month some marijuana stocks have been able to rise in trading before dropping back down. Recently companies have been reporting earnings which is showing increased profits for some. This along with other factors has contributed to the recent pops in the cannabis sector. Yet for most days many top pot stocks continue to find trouble in sustaining better trading.
Cansortium Inc. (OTCQB:CNTMF) Q2 2024 Earnings Conference Call August 22, 2024 4:30 PM ET Company Participants Robert Beasley - Chief Executive Officer Patricia Fonseca - Chief Financial Officer Conference Call Participants Operator Good afternoon, ladies and gentlemen, and welcome to the Cansortium's Second Quarter 2024 Conference Call. Joining us today is the company's CEO, Robert Beasley; and the company's CFO, Patricia Fonseca.
As the cannabis industry continues to evolve, investors keep a close eye on promising stocks. In August, three US marijuana stocks stand out: Cansortium Inc. (CNTMF), Planet 13 Holdings Inc. (PLNH), and Ascend Wellness Holdings Inc. (AAWH). The US cannabis market is projected to grow significantly, reaching $41 billion by 2025. This growth is driven by increasing legalization and consumer demand. Additionally, the US Senate recently passed a bill to expand medical marijuana research. This development is a positive sign for future federal legalization. Furthermore, the growing acceptance of cannabis presents a lucrative opportunity for investors. Consequently, as more states legalize cannabis and consumer interest rises, the potential for significant returns increases. However, it is essential to approach these investments with proper risk management.